Quantitative Proteomic and Transcriptional Analysis of the Response to the p38 Mitogen-activated Protein Kinase Inhibitor SB203580 in Transformed Follicular Lymphoma Cells
Open Access
- 1 August 2004
- journal article
- Published by Elsevier BV in Molecular & Cellular Proteomics
- Vol. 3 (8), 820-833
- https://doi.org/10.1074/mcp.m400008-mcp200
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesisOncogene, 2003
- Novel Substituted Pyridinyl Imidazoles as Potent Anticytokine Agents with Low Activity against Hepatic Cytochrome P450 EnzymesJournal of Medicinal Chemistry, 2003
- cAMP elevators inhibit LPS-induced IL-12 p40 expression by interfering with phosphorylation of p38 MAPK in Murine Peritoneal MacrophagesCell Research, 2002
- Global and Specific Translational Control by Rapamycin in T Cells Uncovered by Microarrays and ProteomicsJournal of Biological Chemistry, 2002
- ROLE OF P38 MAPK, AP-1, AND NF-κB IN INTERLEUKIN-1β-INDUCED IL-8 EXPRESSION IN HUMAN VASCULAR SMOOTH MUSCLE CELLSCytokine, 2002
- MAP Kinases in the Immune ResponseAnnual Review of Immunology, 2002
- The Transcriptional Program in the Response of Human Fibroblasts to SerumScience, 1999
- Codeletion ofCDKN2 andMTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphomaGenes, Chromosomes and Cancer, 1998
- A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian CellsScience, 1994
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990